93 related articles for article (PubMed ID: 9190550)
1. [Immune responses of IgG, IgA and anti-CagA IgG to Helicobacter pylori in dyspeptic and peptic ulcer patients].
Tamássy K; Auli P; Fekete B; Antonello C
Orv Hetil; 1997 Apr; 138(16):985-8. PubMed ID: 9190550
[TBL] [Abstract][Full Text] [Related]
2. [Helicobacter pylori CagA antigen antibodies].
Havlasová J; Bures J; Rejchrt S; Voxová B; Krejsek J
Cas Lek Cesk; 1998 Jun; 137(13):404-9. PubMed ID: 9748734
[TBL] [Abstract][Full Text] [Related]
3. [Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases].
Yang G; Hu F; Jia J
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):648-50. PubMed ID: 11798940
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of Helicobacter pylori CagA-positive strains: gastroduodenal peptic lesions marker.
Martín Guerrero JM; Hergueta Delgado P; Esteban Carretero J; Romero Castro R; Pellicer Bautista FJ; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2000 Mar; 92(3):160-73. PubMed ID: 10799946
[TBL] [Abstract][Full Text] [Related]
5. [Helicobacter pylori genotypes and their association with host's immune response].
Garza-González E; Pérez-Pérez GI; Tijerina-Menchaca R; Maldonado-Garza HJ; Bosques-Padilla FJ
Rev Gastroenterol Mex; 2002; 67(3):155-60. PubMed ID: 12653051
[TBL] [Abstract][Full Text] [Related]
6. Frequencies of serum antibodies to Helicobacter pylori CagA and VacA in a Turkish population with various gastroduodenal diseases.
Sezikli M; Guliter S; Apan TZ; Aksoy A; Keles H; Ozkurt ZN
Int J Clin Pract; 2006 Oct; 60(10):1239-43. PubMed ID: 16669834
[TBL] [Abstract][Full Text] [Related]
7. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM
Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
[TBL] [Abstract][Full Text] [Related]
8. Relationship between mucosal levels of Helicobacter pylori-specific IgA, interleukin-8 and gastric inflammation.
Zhang QB; Etolhi G; Dawodu JB; Gemmell CG; Russell RI
Clin Sci (Lond); 1999 Apr; 96(4):409-14. PubMed ID: 10087249
[TBL] [Abstract][Full Text] [Related]
9. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
[TBL] [Abstract][Full Text] [Related]
10. Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer.
Ilie M; Dascălu L; Chifiriuc C; Popa M; Constantinescu G; Tănăsescu C; Baltac A
Roum Arch Microbiol Immunol; 2011; 70(3):101-4. PubMed ID: 22570922
[TBL] [Abstract][Full Text] [Related]
11. Influence of bacterial CagA status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients.
Parente F; Imbesi V; Maconi G; Cucino C; Sangaletti O; Vago L; Bianchi Porro G
Am J Gastroenterol; 1998 Jul; 93(7):1073-9. PubMed ID: 9672333
[TBL] [Abstract][Full Text] [Related]
12. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
13. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antibodies against heat-stable antigens from Helicobacter pylori in patients with dyspeptic symptoms and normal persons.
Andersen LP; Raskov H; Elsborg L; Holck S; Justesen T; Fischer Hansen B; Møller Nielsen C; Gaarslev K
APMIS; 1992 Sep; 100(9):779-89. PubMed ID: 1389098
[TBL] [Abstract][Full Text] [Related]
15. Can anti-Helicobacter pylori and anti-CagA antibodies be used to select patients with dyspepsia for gastroscopy?
Manjunath SM; Desai ND; Alexander J; Patil S; Ughade S; Sawant P
Trop Gastroenterol; 2006; 27(3):122-6. PubMed ID: 17310555
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori density and cagA status in cirrhotic patients: a case-control study.
Zullo A; Sanchez-Mete L; Hassan C; Diana F; Festuccia F; Attili AF; Morini S
J Gastroenterol Hepatol; 2004 Oct; 19(10):1174-8. PubMed ID: 15377296
[TBL] [Abstract][Full Text] [Related]
17. Anti-CagA and anti-VacA antibodies in Helicobacter pylori-infected patients with and without peptic ulcer disease in Serbia and Montenegro.
Sokic-Milutinovic A; Wex T; Todorovic V; Milosavljevic T; Malfertheiner P
Scand J Gastroenterol; 2004 Mar; 39(3):222-6. PubMed ID: 15074390
[TBL] [Abstract][Full Text] [Related]
18. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori cagA and iceA genotypes status and risk of peptic ulcer in Saudi patients.
Momenah AM; Tayeb MT
Saudi Med J; 2007 Mar; 28(3):382-5. PubMed ID: 17334464
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
